Four out of the eight family members have been diagnosed with liver cancer
Hepatitis B virus infection and hepatitis C virus infection can significantly increase the incidence of liver cancer. Vietnam is one of the countries with high incidence of hepatitis. Vietnamese media reported that the number of hepatitis B virus carriers account for more than 10% of the national population and the number of hepatitis C virus carriers account for 0.4%-4.1% of the national population.
Zhang Jinmei, 46 years old, is from Ho Chi Minh City. She was born in a family with a medical history of hepatitis B. In the past few years, four out of the eight family members have been diagnosed with liver cancer. Her fourth brother passed away not long after his advanced liver cancer diagnosis. Her elder brother is receiving treatment in Europe and is currently in stable condition. In June 2012, Zhang Jinmei was found to have primary hepatic carcinoma during her physical examination at a local hospital. From July 2012 to January 2014, she underwent three cycles of TACE (transcatheter arterial chemoembolization) at a local hospital. However, the tumor did not shrink instead it grew bigger. Her doctor in Vietnam suggested her to do operation but she refused.
In order to seek more appropriate treatment methods, Zhang Jinmei’s elder sister found on the Internet that Fuda Cancer Hospital offers minimally invasive treatments for cancer, which have attracted patients from dozens of countries.
On May 9, 2014, Zhang Jinmei was admitted into Fuda Cancer Hospital. After completed relevant examinations, she underwent interventional chemotherapy and brachytherapy. The procedures went smoothly.
The mother and daughter both choose Fuda Cancer Hospital for cancer treatment
On May 26, 2014, Zhang Jinmei came to Guangzhou again with her 74-year-old mom who was also suffering from liver cancer.
Zhang Jinmei recalled, “After my liver cancer diagnosis in 2012, my mom was also diagnosed with liver cancer several months later. My mom has undergone various treatments at a local hospital but none of them showed good therapeutic effect. That’s why my brother and I suggested her to do treatment here.”
Zhang Jinmei’s mom said, “To be honest, I took a skeptical attitude towards the treatments offered here upon my admission. But soon, I found that my worries are really unnecessary. My doctors are very experienced and made the treatment plan for me after I completed relevant examinations. ”
On May 29, 2014, Zhang Jinmei’s mother underwent argon-helium cryosurgery. The procedure went smoothly and her cancer showed remission.
In May 2014, Zhang Jinmei was found to have lung metastases during her re-examination in Vietnam. Then, she made another trip to Fuda Cancer Hospital. Zhang Jinmei underwent three times of cryosurgery on liver tumors and one time of cryosurgery on left lung tumor from August 2014 to June 2015. She has had good postoperative recovery.
On May 9, 2015, Zhang Jinmei and her mother returned to Fuda Cancer Hospital for re-examination. The examination result of Ms. Zhang’s mother showed no tumor recurrence while hers showed residual active lesions in the left lower lung. Then, Zhang Jinmie received another cycle of cryosurgery.
To give a thumb-up to the doctors for their patience, care and sincerity
“I would like to thank chief physician Wang Jiannan, attending doctor Zhou Zhanchun, resident doctor Zhu Song, and resident doctor Lin Yuguo for answering our questions patiently. We are also very touched that Chief president Xu Kecheng also took time off from his busy schedule to visit us.”
“It’s been very difficult for my family in the past two years. All my families are hepatitis B virus carriers. My elder son and youngest daughter are both suffering from liver cancer and my fourth son also died of liver cancer. But now we are fortunate to have the encouragement from the medical staffs at FUDA, who always cheer us up whenever they saw us. I feel that I’m not only a cancer patient but also a family member of theirs. They can understand our sense of helplessness and make us feel the warmth from families.” Ms. Zhang’s mother said.
Infection of hepatitis B virus increases the risk of getting liver cancer
Li Jiangliang, director of Cancer Prevention and Rehabilitation Center of Guangzhou Fuda Cancer Hospital noted malignant cancer is a major killer in the world while liver cancer is also a major disease that is posing threat to people’s life in China. In the fight against liver cancer, the premise of treatment is prevention, which could minimize the occurrence rate of liver cancer, and improve the early diagnostic rate of liver cancer,, improve the curative effect of cancer treatment and prolong the lifespan of the nationals.
Notably, infection of hepatitis B virus and hepatitis C virus will significantly increase the occurrence of liver cancer. The risk of getting liver cancer among hepatitis B virus carriers is 15 to 20 times higher than that among healthy people. Therefore, proper use of hepatitis B vaccine is an effective means to lower the risk of getting liver cancer. Not only baby child should receive hepatitis B vaccine injection but also adults who haven’t received the injection or who have received the injection but showed hepatitis B antibody negative. Apart from hepatitis B vaccine injection, other routes of transmission should also be severed, including receiving injection, acupuncture or oral treatment in unregulated medical institutions.
Expert profile:
Dr. Li Jiangliang was graduated from Norman Bethune Health Science Center of Jilin University in 1999. He obtained his master degree of medical immunology at Institute of Virology, China Center for Disease Control and Prevention in 2005. He obtained his Doctoral Degree of Molecular Chemistry and Molecular Biology at Peking Union Medical College. Served as a research assistant at the Medical School of the Chinese University of Hong Kong from 2009 to 2010, he currently serves as the director of Cancer Prevention and Rehabilitation Center of Guangzhou Fuda Cancer Hospital.
没有评论:
发表评论